Clinical activity and biomarkers of MEDI4736, an anti-PD-L1 antibody, in patients with NSCLC.
Julie R. Brahmer
Research Funding - MedImmune
Other Remuneration - MedImmune
Naiyer A. Rizvi
Consultant or Advisory Role - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb; MedImmune; Roche/Genentech
Jose Lutzky
Research Funding - MedImmune
Samir Khleif
Research Funding - MedImmune
Andy Blake-Haskins
Employment or Leadership Position - MedImmune
Stock Ownership - AstraZeneca
Xia Li
Employment or Leadership Position - MedImmune
Paul B. Robbins
Employment or Leadership Position - MedImmune
Stock Ownership - AstraZeneca
Jim Vasselli
Employment or Leadership Position - MedImmune
Stock Ownership - AstraZeneca
Ramy A. Ibrahim
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
Scott Joseph Antonia
Consultant or Advisory Role - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb
Research Funding - MedImmune